Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 6Terminated 4

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Classical hematology 3Other 1

Conditions

Venous Thromboembolism 5Venous Thrombosis 4Neoplasms 4Pulmonary Embolism 3Thrombosis 1Thromboembolism 1Pancreatic Neoplasms 1Obesity 1Multiple Myeloma 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1

Interventions

Gemcitabine 34pembrolizumab 26Paclitaxel 21Cyclophosphamide 21Docetaxel 20Carboplatin 20Irinotecan 19Capecitabine 19Fluorouracil 17Bevacizumab 15Dexamethasone 14fludarabine 13Oxaliplatin 13Leucovorin 13Blood Specimen Collection 13Everolimus 12Cetuximab 12Ipilimumab 11Erlotinib Hydrochloride 11Rituximab 10Pemetrexed 10Cisplatin 10venetoclax 9Temozolomide 9Sunitinib 9Nivolumab 9Trastuzumab 8Interleukin-2 8aldesleukin 7Epoetin Alfa 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Neoplasms × Dalteparin × Clear all
NCT03297359 2024-01-23

WAVe

Ottawa Hospital Research Institute

Phase 2 Terminated
92 enrolled
Classical hematologyOther

Neoplasms, Obesity, Venous Thromboembolism

NCT00041782 2018-10-31

Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients

M.D. Anderson Cancer Center

Phase 2 Terminated
26 enrolled

Neoplasms, Venous Thrombosis

NCT01817257 2018-10-29

ALICAT

Cardiff University

Phase 2 Terminated
2 enrolled
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT01164046 2014-12-03

Longheva

University Medical Center Groningen

Phase 3 Terminated
56 enrolled
Classical hematology

Neoplasms, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡